Patents by Inventor Shouwen Wang

Shouwen Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of modulating tissue growth using Frzb protein
    Patent number: 7563596
    Abstract: An isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation. Frzb binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes. The cDNA and protein sequences of human, bovine and Xenopus Frzb are provided. Production and purification of recombinant Frzb are also described.
    Type: Grant
    Filed: July 18, 2005
    Date of Patent: July 21, 2009
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Frank P. Luyten, Malcolm Moos, Jr., Bang Hoang, Shouwen Wang
  • Isolation and method of using tissue growth-inducing Frzb
    Publication number: 20060149050
    Abstract: An isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation. Frzb binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes. The cDNA and protein sequences of human, bovine and Xenopus Frzb are provided. Production and purification of recombinant Frzb are also described.
    Type: Application
    Filed: March 6, 2006
    Publication date: July 6, 2006
    Inventors: Frank Luyten, Malcolm Moos, Bang Hoang, Shouwen Wang
  • Isolation and method of using tissue growth-inducing Frzb protein
    Patent number: 7049291
    Abstract: An isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation. Frzb binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes. The cDNA and protein sequences of human, bovine and Xenopus Frzb are provided. Production and purification of recombinant Frzb are also described.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: May 23, 2006
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Frank P. Luyten, Malcolm Moos, Jr., Bang Hoang, Shouwen Wang
  • Method of modulating tissue growth using Frzb protein
    Publication number: 20050256052
    Abstract: An isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation. Frzb binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes. The cDNA and protein sequences of human, bovine and Xenopus Frzb are provided. Production and purification of recombinant Frzb are also described.
    Type: Application
    Filed: July 18, 2005
    Publication date: November 17, 2005
    Inventors: Frank Luyten, Malcolm Moos, Bang Hoang, Shouwen Wang
  • Method of modulating tissue growth using Frzb Protein
    Patent number: 6924367
    Abstract: An isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle, and nerve tissue formation. Frzb binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes. The cDNA and protein sequences of human, bovine and Xenopus Frzb are provided. Production and purification of recombinant Frzb are also described.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: August 2, 2005
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Frank P. Luyten, Malcolm Moos, Jr., Bang Hoang, Shouwen Wang
  • Isolation and use of tissue growth-inducing Frzb protein
    Patent number: 6884871
    Abstract: An isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation. The CDNA and protein sequences of human and bovine frzb are provided. Production and purification of recombinant Frzb are also described.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: April 26, 2005
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Frank P. Luyten, Malcolm Moos, Jr., Bang Hoang, Shouwen Wang
  • Isolation and use of tissue growth-inducing Frzb protein
    Publication number: 20030139591
    Abstract: An isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation. The CDNA and protein sequences of human and bovine frzb are provided. Production and purification of recombinant Frzb are also described.
    Type: Application
    Filed: December 7, 2001
    Publication date: July 24, 2003
    Inventors: Frank P. Luyten, Malcolm Moos, Bang Hoang, Shouwen Wang
  • Isolation and method of using tissue growth-inducing Frzb protein
    Publication number: 20030009023
    Abstract: An isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation. Frzb binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes. The cDNA and protein sequences of human, bovine and Xenopus Frzb are provided. Production and purification of recombinant Frzb are also described.
    Type: Application
    Filed: February 28, 2002
    Publication date: January 9, 2003
    Inventors: Frank P. Luyten, Malcolm Moos, Bang Hoang, Shouwen Wang
  • Method of modulating tissue growth using Frzb protein
    Publication number: 20020147329
    Abstract: An isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle, and nerve tissue formation. Frzb binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes. The cDNA and protein sequences of human, bovine and Xenopus Frzb are provided. Production and purification of recombinant Frzb are also described.
    Type: Application
    Filed: December 19, 2001
    Publication date: October 10, 2002
    Inventors: Frank P. Luyten, Malcolm Moos, Bang Hoang, Shouwen Wang
  • Production and use of anti-dorsalizing morphogenetic protein
    Patent number: 5693779
    Abstract: An isolated polynucleotide of anti-dorsalizing morphogenetic protein (ADMP-1) is obtained from Xenopus. The protein is most closely related to human BMP-3. ADMP-1 functions as a modulator for dorsalizing influences, and prevents syndromes involving inappropriate proliferation of tissues.
    Type: Grant
    Filed: November 8, 1994
    Date of Patent: December 2, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Malcolm Moos, Jr., Marie Krinks, Shouwen Wang